Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA cross-linking reagents are not individual molecular targets but rather a broad class of chemical compounds capable of covalently linking two nucleotides within the same strand (intrastrand) or across complementary strands (interstrand) in double-stranded DNA. These reagents include both natural and synthetic chemicals—such as alkylating agents (e.g., nitrogen mustards), platinum-based drugs (e.g., cisplatin), mitomycins, and psoralens—that disrupt essential cellular processes by preventing proper unwinding or separation of the genetic material during replication and transcription. The resulting lesions can trigger cell cycle arrest and apoptosis if unrepaired. Because rapidly dividing cancer cells are particularly susceptible to this type of damage, many clinically important chemotherapeutic drugs act via this mechanism. However, their use is limited by significant toxicity due to effects on healthy proliferative tissues[1][2][4]. Note: "DNA cross-linking reagent" is not itself a protein target such as an enzyme or receptor; it refers instead to a functional group/classification for small molecules used primarily in research or therapy. If you require information about specific protein targets affected by these reagents—such as particular repair enzymes involved in resolving these lesions—please specify further.
Covalent binding to nucleotides within or between strands of the DNA double helix, forming intra-strand or inter-strand crosslinks that block replication and transcription[1][2][4]
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA cross-linking reagent.